Sinopharm
1099.HK
#1870
Rank
ยฃ6.85 B
Marketcap
ยฃ2.20
Share price
-0.23%
Change (1 day)
15.12%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Sinopharm (1099.HK) - Total liabilities

Total liabilities on the balance sheet as of December 2023 : ยฃ29.60 Billion

According to Sinopharm's latest financial reports the company's total liabilities are ยฃ29.60 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sinopharm - Total liabilities on balance sheet (from 2008 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31ยฃ30.48 B11.21%
2021-12-31ยฃ27.40 B10.12%
2020-12-31ยฃ24.89 B18.17%
2019-12-31ยฃ21.06 B9.78%
2018-12-31ยฃ19.18 B27.09%
2017-12-31ยฃ15.09 B14.29%
2016-12-31ยฃ13.20 B28.74%
2015-12-31ยฃ10.26 B7.09%
2014-12-31ยฃ9.58 B24.47%
2013-12-31ยฃ7.69 B33.33%
2012-12-31ยฃ5.77 B19.39%
2011-12-31ยฃ4.83 B80.84%
2010-12-31ยฃ2.67 B58.7%
2009-12-31ยฃ1.68 B32.36%
2008-12-31ยฃ1.27 B58.08%
2007-12-31ยฃ0.80 B36.81%
2006-12-31ยฃ0.58 B